BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 6330871)

  • 21. Prevention of duodenal ulcer relapse with ranitidine.
    Mekel RC; den Boer DJ
    S Afr Med J; 1985 Sep; 68(6):385-6. PubMed ID: 3898417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
    Baglioni A; Barbara L; Bianchi-Porro G; Blasi A; Canelli B; Cheli R; Dal Monte R; Dammann HG; Francavilla A; Hentschel E
    Z Gastroenterol; 1985 Dec; 23(12):665-9. PubMed ID: 2868581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Controlled study with ranitidine for the prevention of recurrent duodenal ulcer].
    Ocaña Andrade E; Porras Katz JC; Beltrán Escobar G; Jáuregui Garduño JL
    Rev Gastroenterol Mex; 1997; 62(2):94-7. PubMed ID: 9471669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ranitidine and cimetidine in long-term (2 years) maintenance therapy of chronic gastric ulcer].
    Varas MJ
    Rev Esp Enferm Apar Dig; 1989 Feb; 75(2):153-6. PubMed ID: 2652217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year maintenance treatment with ranitidine: effects on the natural history of duodenal ulcer disease.
    Susi D; Neri M; Ballone E; Mezzetti A; Cuccurullo F
    Am J Gastroenterol; 1994 Jan; 89(1):26-32. PubMed ID: 8273793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind endoscopically controlled trial of ranitidine in a high incidence area.
    Moshal MG; Spitaels JM; Khan F
    Scand J Gastroenterol Suppl; 1981 Jun; 69():129-31. PubMed ID: 6119777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine.
    Reynolds JC; Schoen RE; Maislin G; Zangari GG
    Am J Gastroenterol; 1994 Apr; 89(4):571-80. PubMed ID: 8147361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ranitidine in uncomplicated duodenal ulceration. A double-blind endoscopically controlled trial.
    Moshal MG; Spitaels JM; Khan F
    S Afr Med J; 1981 Sep; 60(10):393-4. PubMed ID: 6269234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of peptic ulcer maintenance trials.
    Robinson M
    Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter, double-blind, randomized controlled study of omeprazole versus ranitidine in the treatment of duodenal ulcer in Israel.
    Arber N; Avni Y; Eliakim R; Swissa A; Melzer E; Rachmilewitz D; Konikoff F
    Isr J Med Sci; 1994 Oct; 30(10):757-61. PubMed ID: 7960688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ranitidine, cimetidine and antacids in the prevention of recurrence after healed duodenal ulcer: one-year experience.
    Bresci G; Capria A; Rindi G; Geloni M; Federici G; Corsini G
    Int J Tissue React; 1983; 5(4):345-8. PubMed ID: 6323335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapse prevention of duodenal ulcers with trimipramine, cimetidine, or placebo. A double-blind comparison.
    Becker U; Faurschou P; Jensen J; Lindorff K; Pedersen PB; Ranløv PJ
    Scand J Gastroenterol; 1984 May; 19(3):405-10. PubMed ID: 6377466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric ulcer: a double blind comparison of 800 mcg misoprostol versus 300 mg ranitidine.
    Gonvers JJ; Aenishänslin W; Backwinkel K; Bretholz A; Egger G; Feyerabend H; Fumagalli I; Güller R; Hammer B; Mattle WP
    Hepatogastroenterology; 1987 Oct; 34(5):233-5. PubMed ID: 3119449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
    Gut; 1990 Jun; 31(6):653-6. PubMed ID: 2199347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of duodenal ulcer occurrence. Double-blind comparison of ranitidine and cimetidine.
    Bolin TD; Davis AE; Billington B
    J Clin Gastroenterol; 1987 Jun; 9(3):310-3. PubMed ID: 3302004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early evening ranitidine administration promotes faster duodenal ulcer healing.
    Merki H; Witzel L; Hüttemann W; Ansari A; Panijel M; Harre K; Heim J; Wolbergs E; Neumann HJ; Röhmel J
    Am J Gastroenterol; 1988 Apr; 83(4):362-4. PubMed ID: 3279756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ranitidine, cimetidine and placebo in the short and longer term treatment of duodenal ulcer].
    Klinger J; Maggiolo P; Goić A
    Rev Med Chil; 1984 Apr; 112(4):337-41. PubMed ID: 6091211
    [No Abstract]   [Full Text] [Related]  

  • 38. Ranitidine multicenter study on slow-response duodenal ulcer patients.
    Uleri S; Visona G; Castelli G
    Hepatogastroenterology; 1994 Feb; 41(1):54-7. PubMed ID: 8175117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing overnight secretion of acid to heal duodenal ulcers. Comparison of standard divided dose of ranitidine with a single dose administered at night.
    Colin-Jones DG; Ireland A; Gear P; Golding PL; Ramage JK; Williams JG; Leicester RJ; Smith CL; Ross G; Bamforth J
    Am J Med; 1984 Nov; 77(5B):116-22. PubMed ID: 6095655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of gastric ulcer with ranitidine.
    Schulz TB; Berstad A; Rydning A; Frislid K
    Scand J Gastroenterol; 1984 Jan; 19(1):119-21. PubMed ID: 6324332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.